Human immunodeficiency virus type 1 T-cell tropism is determined by events prior to provirus formation
about
Pathogenesis of human immunodeficiency virus infectionDefinition of the stage of host cell genetic restriction of replication of human immunodeficiency virus type 1 in monocytes and monocyte-derived macrophages by using twins.Phenotype-associated env gene variation among eight related human immunodeficiency virus type 1 clones: evidence for in vivo recombination and determinants of cytotropism outside the V3 domain.Inhibition of telomerase activity alters tight junction protein expression and induces transendothelial migration of HIV-1-infected cells.Changes in HPV infection in patients with anogenital warts and their partnersFusogenic selectivity of the envelope glycoprotein is a major determinant of human immunodeficiency virus type 1 tropism for CD4+ T-cell lines vs. primary macrophagesDevelopment of hexadecyloxypropyl tenofovir (CMX157) for treatment of infection caused by wild-type and nucleoside/nucleotide-resistant HIV.Combined effect of CCR5-Delta32 heterozygosity and the CCR5 promoter polymorphism -2459 A/G on CCR5 expression and resistance to human immunodeficiency virus type 1 transmissionHemofiltrate CC chemokine 1[9-74] causes effective internalization of CCR5 and is a potent inhibitor of R5-tropic human immunodeficiency virus type 1 strains in primary T cells and macrophagesStructure-function analysis of the epitope for 4E10, a broadly neutralizing human immunodeficiency virus type 1 antibody.CD4-specific transgenic expression of human cyclin T1 markedly increases human immunodeficiency virus type 1 (HIV-1) production by CD4+ T lymphocytes and myeloid cells in mice transgenic for a provirus encoding a monocyte-tropic HIV-1 isolate.Antiviral effects of human immunodeficiency virus type 1-specific small interfering RNAs against targets conserved in select neurotropic viral strains.Development of real-time PCR array for simultaneous detection of eight human blood-borne viral pathogens.Genetic association of the antiviral restriction factor TRIM5alpha with human immunodeficiency virus type 1 infectionOral administration of the nucleoside EFdA (4'-ethynyl-2-fluoro-2'-deoxyadenosine) provides rapid suppression of HIV viremia in humanized mice and favorable pharmacokinetic properties in mice and the rhesus macaquePosttranscriptional m(6)A Editing of HIV-1 mRNAs Enhances Viral Gene Expression.Models for predicting effective HIV chemoprevention in womenSuperior human leukocyte reconstitution and susceptibility to vaginal HIV transmission in humanized NOD-scid IL-2Rγ(-/-) (NSG) BLT mice.The tyrosine kinase inhibitor genistein blocks HIV-1 infection in primary human macrophages.Extracellular Vpr protein increases cellular permissiveness to human immunodeficiency virus replication and reactivates virus from latency.Sequences regulating tropism of human immunodeficiency virus type 1 for brain capillary endothelial cells map to a unique region on the viral genome.Cell type-specific fusion cofactors determine human immunodeficiency virus type 1 tropism for T-cell lines versus primary macrophages.Progress toward a human CD4/CCR5 transgenic rat model for de novo infection by human immunodeficiency virus type 1.No SEVI-mediated enhancement of rectal HIV-1 transmission of HIV-1 in two humanized mouse cohortsHuman immunodeficiency virus type 1 variants with increased replicative capacity develop during the asymptomatic stage before disease progressionCryptic nature of envelope V3 region epitopes protects primary monocytotropic human immunodeficiency virus type 1 from antibody neutralization.Human immunodeficiency virus type 1 infection of the brain.Phenotypic heterogeneity in a panel of infectious molecular human immunodeficiency virus type 1 clones derived from a single individual.Mapping genetic determinants for human immunodeficiency virus type 1 resistance to soluble CD4.Two amino acid substitutions within the capsid are coordinately required for acquisition of fibrotropism by the lymphotropic strain of minute virus of miceThe surface envelope protein gene region of equine infectious anemia virus is not an important determinant of tropism in vitro.Macrophages sustain HIV replication in vivo independently of T cellsHuman immunodeficiency virus type 1 infection increases the in vivo capacity of peripheral monocytes to cross the blood-brain barrier into the brain and the in vivo sensitivity of the blood-brain barrier to disruption by lipopolysaccharide.Identification of human immunodeficiency virus envelope gene sequences influencing viral entry into CD4-positive HeLa cells, T-leukemia cells, and macrophages.Inhibition of Heat Shock Protein 90 Prevents HIV ReboundPPARalpha and PPARgamma attenuate HIV-induced dysregulation of tight junction proteins by modulations of matrix metalloproteinase and proteasome activities.R5 human immunodeficiency virus type 1 (HIV-1) replicates more efficiently in primary CD4+ T-cell cultures than X4 HIV-1.Human immunodeficiency virus type 1 V1-to-V5 envelope variants from the chronic phase of infection use CCR5 and fuse more efficiently than those from early after infection.Impaired viral entry cannot explain reduced CD4+ T cell susceptibility to HIV type 1 in certain highly exposed individuals.Envelope proteins from clinical isolates of human immunodeficiency virus type 1 that are refractory to neutralization by soluble CD4 possess high affinity for the CD4 receptor.
P2860
Q24634681-0C6BDD4C-3ECD-4444-B565-5F237BAD0119Q27469707-F0093E2E-49ED-4E5F-B70F-A7A201D63FF4Q33719811-78332902-EE04-4EB7-87C0-B889F6B2BAB8Q33784426-C3A7EF3B-C6A1-4C33-AA3E-99A8FEA8E782Q33934630-FFA6E757-95C7-4FC6-B458-2FE2F63D7E1AQ33944466-150381E0-3775-44BA-B586-5C19BC2E50CDQ33962846-96DCF8D6-7449-45D7-9BBC-EFD7CDE5E6FBQ33987424-2F138CC1-BE5E-406C-BB18-B05F668493D8Q34106131-7B7186CB-39BB-4EA9-823C-66178452B9B7Q34353296-F44FAC05-792E-406C-A468-9B77248E6398Q34353412-5FF1548F-6AC4-499B-8AD0-0F75C11F7CADQ34371320-651D99A4-8E8D-4696-B573-7B7D3F4C43F9Q34389449-E2938676-4879-4153-A709-5D187049CDF5Q34434675-7E061EC2-7CBF-488C-9686-255AAD3D0871Q34475019-E5829CBC-03F9-43DE-9C42-A7FA0B8EF910Q34523721-10A8456E-7AC4-443A-A632-3ED5669B8933Q35102285-9F849BC9-A272-466E-B70D-798E94F0E36BQ35154146-74925ADE-FDD2-4BD9-9CD4-CF1BAAB45335Q35741691-F1907BEC-E6EB-48E6-AD9B-5830339B91D1Q35832979-9726DA00-E340-4B25-8A1E-51F7825A7AC7Q35860976-86C51061-858E-4C43-87E9-C18D6F2AC930Q35866377-341BA0C5-20CC-4F48-A4A0-330A5678B7DEQ36370241-6B5354A0-7AE5-4321-B24B-2168461517BFQ36553615-2888309B-B67D-46B4-8E90-BE1AFA032B10Q36622258-4EF47266-CB20-4AE9-B90C-A7C72A12E14BQ36635390-11E64EC5-9F16-4D8E-A125-D92226C0D6CAQ36640545-A9A3994C-6FF5-46F1-9B00-58ED5C886ED5Q36684257-0BA874AA-B1FE-476E-B174-1EF520D3EAB1Q36697574-BABC28C9-975B-4AAE-ABA9-7DB3959639BFQ36697947-744BAEB0-D101-47A7-9214-DB3134E35CEAQ36698743-541BFEB8-683A-4D42-8922-713DB4AB5B1DQ36737917-FDEE5211-288A-4484-ADA0-98AFE24C28AAQ36804543-2473B928-7063-4593-A398-8D3A910D0472Q36820658-16816050-B43F-4CB0-B59E-FBF014A66F0DQ36876244-FD0FCBC9-DC8A-4B3E-B570-7766D375DB8DQ37159206-70AF3EAF-93D3-42EC-8A2C-8DA2C5BF35A5Q37348991-69F64840-CA20-4327-92D9-03F28A5AEE03Q37356028-77813146-A159-4E37-8519-C68A79B33D76Q37393689-8DDABEA8-2A99-40D0-A387-C45BDFBA642CQ37588188-60FB2C9C-2F87-462A-99ED-AC00E2EEC888
P2860
Human immunodeficiency virus type 1 T-cell tropism is determined by events prior to provirus formation
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
1990年论文
@zh
1990年论文
@zh-cn
name
Human immunodeficiency virus t ...... ts prior to provirus formation
@en
type
label
Human immunodeficiency virus t ...... ts prior to provirus formation
@en
prefLabel
Human immunodeficiency virus t ...... ts prior to provirus formation
@en
P2093
P2860
P1433
P1476
Human immunodeficiency virus t ...... ts prior to provirus formation
@en
P2093
Koyanagi Y
P2860
P304
P407
P577
1990-10-01T00:00:00Z